Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D020106 |
Acrylamide |
Acrylamide results in decreased expression of GAP43 mRNA | decreases expression | 15749267
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GAP43 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of GAP43 mRNA | decreases expression | 11377751
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of GAP43 mRNA | increases expression | 11377751
|
D001151 |
Arsenic |
Arsenic results in decreased expression of GAP43 mRNA | decreases expression | 19654921
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 18004999
|
D004390 |
Chlorpyrifos |
Chlorpyrifos affects the expression of GAP43 mRNA | affects expression | 17452286
|
D003010 |
Clorgyline |
Clorgyline results in decreased expression of GAP43 protein | decreases expression | 12480131
|
C010902 |
decabromobiphenyl ether |
decabromobiphenyl ether affects the expression of GAP43 protein | affects expression | 18061678
|
C010902 |
decabromobiphenyl ether |
decabromobiphenyl ether results in increased expression of GAP43 protein | increases expression | 18753049
|
D003976 |
Diazinon |
Diazinon results in increased expression of GAP43 mRNA | increases expression | 17452286
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of GAP43 mRNA | increases expression | 16002434
|
D016291 |
Dizocilpine Maleate |
Dizocilpine Maleate inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 8774942
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of GAP43 mRNA | affects cotreatment|decreases expression | 17404688
|
D000431 |
Ethanol |
Ethanol results in decreased expression of GAP43 mRNA | decreases expression | 15940294
|
D000431 |
Ethanol |
Thyroxine inhibits the reaction [Ethanol results in decreased expression of GAP43 mRNA] | decreases expression|decreases reaction | 15940294
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GAP43 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAP43 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of GAP43 mRNA | decreases expression | 17351261 15834898 17557909
|
D015025 |
Zearalenone |
Zearalenone results in decreased expression of GAP43 mRNA | decreases expression | 17557909
|
D005473 |
Fluoxetine |
Fluoxetine results in decreased expression of GAP43 mRNA | decreases expression | 17950272
|
D005690 |
Galactose |
Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] | decreases expression|decreases reaction | 16707173
|
D007099 |
Imipramine |
Imipramine results in decreased expression of GAP43 mRNA | decreases expression | 17950272
|
D007608 |
Kainic Acid |
Dizocilpine Maleate inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 8774942
|
D007608 |
Kainic Acid |
Kainic Acid results in increased expression of GAP43 mRNA | increases expression | 8774942
|
D007608 |
Kainic Acid |
Pentobarbital inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 8774942
|
C063302 |
KN 62 |
KN 62 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 18004999
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of GAP43 mRNA | decreases expression | 12057914
|
D008468 |
Meclizine |
Meclizine affects the expression of GAP43 protein | affects expression | 12388792
|
D008535 |
Megestrol |
Megestrol affects the expression of GAP43 protein | affects expression | 12388792
|
D008704 |
Methazolamide |
Methazolamide affects the expression of GAP43 protein | affects expression | 12388792
|
D009532 |
Nickel |
Nickel affects the expression of GAP43 mRNA | affects expression | 18812211
|
D010424 |
Pentobarbital |
Pentobarbital inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 8774942
|
D010622 |
Phencyclidine |
Phencyclidine results in increased expression of GAP43 mRNA | increases expression | 11377751
|
D011189 |
Potassium Chloride |
1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 18004999
|
D011189 |
Potassium Chloride |
CAMK2D protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | affects reaction|increases expression | 18004999
|
D011189 |
Potassium Chloride |
KN 62 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 18004999
|
D011189 |
Potassium Chloride |
PLD2 protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | affects reaction|increases expression | 18004999
|
D011189 |
Potassium Chloride |
Potassium Chloride results in increased expression of GAP43 mRNA | increases expression | 18004999
|
D011189 |
Potassium Chloride |
Potassium Chloride results in increased expression of GAP43 protein | increases expression | 18004999
|
D011189 |
Potassium Chloride |
U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 18004999
|
D011189 |
Potassium Chloride |
U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 protein] | decreases reaction|increases expression | 18004999
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of GAP43 mRNA | affects cotreatment|decreases expression | 17404688
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] | decreases expression|decreases reaction | 16707173
|
C059514 |
resveratrol |
resveratrol results in decreased expression of GAP43 mRNA | decreases expression | 12002526
|
C010327 |
salinomycin |
salinomycin results in decreased expression of GAP43 mRNA | decreases expression | 19682730
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of GAP43 mRNA | increases expression | 12016162
|
D013467 |
Sulindac |
Sulindac affects the expression of GAP43 protein | affects expression | 12388792
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of GAP43 mRNA | increases expression | 15708448
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of GAP43 protein | increases expression | 15708448
|
D013974 |
Thyroxine |
Thyroxine inhibits the reaction [Ethanol results in decreased expression of GAP43 mRNA] | decreases expression|decreases reaction | 15940294
|
D013974 |
Thyroxine |
Thyroxine results in increased expression of GAP43 mRNA | increases expression | 15940294
|
D013974 |
Thyroxine |
Thyroxine results in decreased expression of GAP43 mRNA | decreases expression | 17403546
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAP43 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GAP43 mRNA | increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of GAP43 protein | increases expression | 16849523
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of GAP43 mRNA | increases expression | 15708448
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of GAP43 protein | increases expression | 15708448 17130476
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | decreases reaction|increases expression | 18004999
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 protein] | decreases reaction|increases expression | 18004999
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of GAP43 mRNA | increases expression | 19101580
|
D014700 |
Verapamil |
Verapamil affects the expression of GAP43 protein | affects expression | 12388792
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
5.06 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
11.77 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
11.77 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
11.77 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.54 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.04 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.04 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.50 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.05 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.74 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
7.74 | 7897758 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.27 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
8.27 | 16166738 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.41 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.41 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
6.41 | 11910360 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.36 | 15688382 |
MESH:D000236 |
Adenoma |
|
Sulindac |
6.36 | 10223192 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
2.95 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.23 | 16460482 11535846 19003578 11874996 12394442 17611924 15623613 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.26 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
12.33 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
12.33 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
7.75 | 16611668 11874814 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
7.75 | 16487989 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.88 | 15451039 15451040 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.27 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.47 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.79 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.58 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.85 | 17084956 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.40 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
18.43 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
18.43 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
18.43 | 11141031 18313124 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
18.43 | 17497229 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.74 | 16251483 12569548 18414634 16835338 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.05 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
10.69 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
10.69 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
10.69 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.16 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.21 | 16456186 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.18 | 7820390 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.55 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
6.01 | 19371607 12928151 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.01 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
2.57 | 18775368 19232924 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.57 | 19232924 17688650 15238991 18558336 18177632 18316065 17157402 17507914 18940202 18985861 19460635 18396377 16609825 20603192 18775368 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.99 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.99 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.85 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.66 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.35 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.08 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.08 | 8888407 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.91 | 11207687 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.90 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.84 | 15665606 15845082 15380490 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.85 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Acrylamide |
7.66 | 18183576 16253758 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
7.66 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
7.66 | 12948864 16675129 18497071 17018787 17289903 17261762 14630087 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
7.66 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
7.66 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
7.66 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
7.66 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
7.66 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
7.66 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
7.66 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
7.66 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.16 | 16813970 |
MESH:D002056 |
Burns |
|
Ethanol |
4.23 | 16374292 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.11 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.03 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.46 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.34 | 17687452 15504454 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.72 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
12.79 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
12.79 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
12.79 | 15763234 18788625 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
12.79 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
12.79 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
12.79 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
12.79 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.16 | 16675471 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.53 | 17234771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
12.81 | 17687452 15504454 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
12.81 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
12.81 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
12.81 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
12.81 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.70 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
18.88 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Methazolamide |
18.88 | 17124262 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
18.88 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
18.88 | 16120746 18850075 18670907 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
18.88 | 18093424 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
6.56 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.56 | 15458977 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.95 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.83 | 17460283 |
MESH:D002418 |
Cattle Diseases |
|
Acrylamide |
5.01 | 12510666 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.75 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
5.75 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.16 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.54 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.56 | 16105132 17333356 17110522 17681005 15861022 16919318 11677210 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.72 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.35 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
8.71 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.71 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
8.71 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
8.23 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.23 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
5.44 | 15741050 11134977 16640504 19440933 17148506 19056647 17191121 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.44 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
5.44 | 12458338 12902858 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.36 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.36 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
3.36 | 10666051 18059344 11197048 11076880 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.70 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.47 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
4.94 | 15451039 11198716 19302082 15513904 11873399 10194807 15451040 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.94 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.94 | 9125849 17551590 9211117 10589399 14991402 16925845 8800419 9142499 9664655 9224671 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
4.94 | 8888407 17688650 16575769 |
MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
7.76 | 15014590 |
MESH:D003866 |
Depressive Disorder |
|
Imipramine |
7.76 | 20305041 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.55 | 19470301 17100760 17244072 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.24 | 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
7.39 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
7.39 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.56 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.82 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
7.82 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.07 | 17187935 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.77 | 12861449 17621415 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
5.44 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.44 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.44 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.44 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.36 | 16487989 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.65 | 1851702 |
MESH:D004487 |
Edema |
|
Fluoxetine |
13.47 | 12798668 |
MESH:D004487 |
Edema |
|
Imipramine |
13.47 | 12798668 |
MESH:D004487 |
Edema |
|
resveratrol |
13.47 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.47 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.48 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.48 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
18.59 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
18.59 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
18.59 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
18.59 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.46 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.46 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
13.19 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
13.19 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
13.19 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.97 | 17637181 15328337 15821434 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.43 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.73 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.48 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.71 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.23 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.88 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.63 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.59 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
4.59 | 12235107 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.76 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.76 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
10.97 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
10.97 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
10.97 | 19224547 14986274 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.22 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.87 | 16946407 15513904 10194807 15451040 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.04 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.45 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.72 | 18558336 8888407 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.64 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
5.05 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
4.70 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
12.39 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.39 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.39 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.12 | 6392382 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.26 | 15046732 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.60 | 11910360 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.25 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
6.31 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.31 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.87 | 17643826 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.15 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.89 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.72 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.74 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.74 | 9664655 14991402 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.01 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.95 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
4.17 | 16487989 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.48 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.59 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.75 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.58 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.80 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.08 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
9.08 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.43 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.61 | 15340226 18606429 8697196 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
6.87 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.87 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.62 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.15 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.66 | 18262572 11834736 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.08 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.63 | 16873680 |
MESH:D006973 |
Hypertension |
|
Arsenic |
11.00 | 9931084 16076760 11953799 |
MESH:D006973 |
Hypertension |
|
Quercetin |
11.00 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.00 | 18850075 18670907 |
MESH:D006973 |
Hypertension |
|
Verapamil |
11.00 | 17700361 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.93 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.12 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.39 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.08 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.08 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Acrylamide |
9.07 | 11020651 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
9.07 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Acrylamide |
13.74 | 12507653 15749267 15355880 11020651 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
13.74 | 12948887 16466525 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
13.74 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
13.74 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Fluoxetine |
24.51 | 12798668 |
MESH:D007249 |
Inflammation |
|
Imipramine |
24.51 | 12798668 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
24.51 | 17237260 17963957 12878042 17255318 9205823 |
MESH:D007249 |
Inflammation |
|
Nickel |
24.51 | 16166738 |
MESH:D007249 |
Inflammation |
|
Progesterone |
24.51 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
24.51 | 16366677 |
MESH:D007249 |
Inflammation |
|
Sulindac |
24.51 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
24.51 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
9.73 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.73 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.68 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.35 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.26 | 10223192 12584176 12628509 12351151 12663524 10213222 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.59 | 11245490 12394442 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.23 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
14.95 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
14.95 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
14.95 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.53 | 17086741 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.56 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
8.67 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
8.67 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.67 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.64 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.79 | 15451040 |
MESH:D007938 |
Leukemia |
|
Quercetin |
5.71 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.71 | 17143497 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
4.88 | 16972261 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.32 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.58 | 16294345 19850784 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.58 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
11.16 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
11.16 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
11.16 | 9834237 16140955 19035177 15748426 16891316 17506722 19075265 16766008 17361223 17217047 16823087 16331271 17294898 19225113 17107899 17301526 16788101 19029980 17712046 16935935 19642359 17368321 17649720 12679006 17339181 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.27 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
7.28 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.28 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Fluoxetine |
7.91 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Imipramine |
7.91 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.13 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.66 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
3.95 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
7.89 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
7.89 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
7.89 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
7.89 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
7.89 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
7.89 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
6.10 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
6.10 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
6.10 | 14986274 16867024 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.23 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
12.34 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
12.34 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
12.34 | 19321006 19812893 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
12.34 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
5.02 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.02 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.88 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.82 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.59 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
5.94 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
5.94 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
5.94 | 17306315 17077188 16712894 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
5.94 | 15713900 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.94 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.90 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.52 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.82 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.02 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
12.02 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
12.02 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
12.02 | 19682730 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.04 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.60 | 17453147 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.59 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.59 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Sulindac |
6.59 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
6.59 | 16752155 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.78 | 15451040 18411066 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.00 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
7.50 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Imipramine |
7.50 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.99 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.88 | 18803445 18765137 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.08 | 1613127 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.16 | 16490592 14749477 17164350 16267019 17935668 17049120 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.44 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.64 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.54 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.54 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.41 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.41 | 17015251 16525036 16456233 17188708 17125593 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
13.33 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
13.33 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
13.33 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.46 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
7.46 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.33 | 17322642 |
MESH:D009207 |
Myoclonus |
|
Fluoxetine |
5.45 | 8041377 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
7.04 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.04 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.04 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.83 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.83 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.30 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Acrylamide |
4.37 | 11264303 12387367 12387366 |
MESH:D009422 |
Nervous System Diseases |
|
Acrylamide |
4.62 | 12164553 12507653 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
13.96 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.96 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
13.96 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
15.00 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
15.00 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
15.00 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
15.00 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.70 | 17652729 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
7.70 | 16850258 17266991 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
15.52 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
15.52 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
15.52 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
3.87 | 15081274 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
5.06 | 20418887 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
8.88 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.88 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
20.59 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
20.59 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
20.59 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
20.59 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
20.59 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
20.59 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
20.59 | 16211241 |
MESH:D010146 |
Pain |
|
Fluoxetine |
13.45 | 12798668 |
MESH:D010146 |
Pain |
|
Imipramine |
13.45 | 12798668 |
MESH:D010146 |
Pain |
|
Sulindac |
13.45 | 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
13.45 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
11.00 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
11.00 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
11.00 | 11504793 16820089 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.00 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.29 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.81 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Acrylamide |
9.00 | 11510240 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
9.00 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.56 | 16905509 6392382 15371236 |
MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
5.58 | 8041377 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.12 | 12224865 11605937 |
MESH:D011041 |
Poisoning |
|
Diazinon |
3.96 | 17603234 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.15 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
3.62 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
13.78 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
13.78 | 11896295 11222880 11118676 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
13.78 | 20603192 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.35 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.50 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.03 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.03 | 16289102 16644109 12479363 18247401 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Clorgyline |
2.03 | 19691856 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.03 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.03 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.03 | 16731767 17804756 17718901 17675339 15767336 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.03 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
7.96 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
7.96 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.89 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.10 | 11422049 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.36 | 16723453 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.59 | 10930210 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.14 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.05 | 17520802 16317513 16314181 15827377 17058453 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.44 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
4.22 | 11874814 17119214 16611668 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.43 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
4.46 | 16611668 17119214 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.54 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.54 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.69 | 18045962 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.11 | 16862918 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.01 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Dizocilpine Maleate |
15.52 | 17157343 11218047 12660363 |
MESH:D012640 |
Seizures |
|
Ethanol |
15.52 | 9754883 |
MESH:D012640 |
Seizures |
|
Kainic Acid |
15.52 | 1641125 10686065 16336964 19186208 14637104 19414003 18657176 17827730 15686955 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
15.52 | 9754883 10087439 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
15.52 | 15475178 16876388 11738929 11044598 17978042 1511512 3137016 14763951 |
MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
5.46 | 8704074 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.65 | 6418539 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.63 | 19834688 17453740 16702368 16353154 6392382 18709164 16759981 17938729 17548696 15952646 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
15.63 | 17976673 16251483 17029826 17050553 15504454 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
15.63 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.63 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.63 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
15.63 | 16467112 |
MESH:D012892 |
Sleep Deprivation |
|
Imipramine |
5.76 | 19798453 |
MESH:D012893 |
Sleep Disorders |
|
Kainic Acid |
5.27 | 19414003 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.50 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.85 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.44 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.44 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.10 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.50 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.50 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.16 | 17918041 9562338 16755016 17189318 9211565 11906479 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.11 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
9.02 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
9.02 | 11529278 9754883 |
MESH:D013733 |
Testicular Diseases |
|
Acrylamide |
4.80 | 15864552 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.79 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.22 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.79 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
10.91 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
10.91 | 19910387 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.70 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.25 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.67 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.67 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.79 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.95 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.09 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
7.38 | 17306315 15987713 11144890 18640142 19322015 19429237 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
7.38 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.38 | 16712894 16452187 11723127 17306315 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.22 | 8888407 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.84 | 16487989 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
13.73 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.73 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
13.73 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
13.78 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
13.78 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
13.78 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.17 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
10.41 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
10.41 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.15 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.15 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.88 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.65 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.81 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.60 | 16287080 |